UltraTech Cement BUY. Higher utilisation & good cost controls offset cost pressure INDIA

Size: px
Start display at page:

Download "UltraTech Cement BUY. Higher utilisation & good cost controls offset cost pressure INDIA"

Transcription

1 INDIA BUY Result Update 26 April 2018 Cement Higher utilisation & good cost controls offset cost pressure UltraTech s (UTCEM) Q4FY18 standalone EBITDA rose 33% YoY buoyed by 31% YoY volume growth (core volume up 8% YoY), and better cost control amid rising input and freight costs. Strong demand bolstered volume growth and boosted utilisation. Continued improvement in energy consumption metrics and lead distance reduction partly moderated the impact of rising energy costs YoY. Amid a good demand outlook, we expect UTCEM to deliver an industry leading 13% volume CAGR during FY18-20E. We also expect UTCEM s margins to benefit from better pricing, UTCEM s economies of scale and prudent cost controls. We reiterate BUY with a revised TP of Rs4,980. Strong demand boost utilisation, driving 31% YoY volume growth: UTCEM s total volume rose 31% YoY and 17% QoQ to 18.5mn MT. Its (ex-jpa) grey sales rose 8% YoY, thus boosting core utilisation to 90% vs 83% YoY and 79% QoQ. Amid good demand and strong distribution, JPA s assets utilisation also firmed up to 75% vs 60% QoQ. Total grey cement utilisation thus rose to 87% vs 83% YoY and 74% QoQ. JPA s assets utilisation has further increased to 85% during Q1. Management guided overall demand traction to remain strong, thus leading to 8-10% industry growth outlook. White/putty volume rose 4% YoY and 21% QoQ to 0.4mn MT. Good demand also led to 2% QoQ blended NSR improvement, leading to 4% YoY NSR increase. On YoY basis, both NSR and freight cost is higher by ~Rs33/MT owing to FOR based reporting. Good cost control amid rising input costs: Unitary opex rose 5% YoY and fell 1% QoQ to Rs3952/MT (vs our est of Rs4006/MT). While waw materials cost remained flat QoQ and YoY (per MT), energy cost increased 4% QoQ and 18% YoY. The QoQ increase in driven by ban on petcoke usage in CPPs leading to increased use of thermal coal (higher per Kcal cost). On YoY basis, rising fuel cost is driving sharp cost inflation. Fuel prices have further increased 10% QoQ in Q1FY19. Freight cost increase (+4% QoQ and 6% YoY) is driven by rising diesel prices (QoQ and YoY) and FOR based reporting (3% increase YoY). On YoY basis, UTCEM moderated cost inflation impact through increased fuel consumption efficiency (3-5%), use of alternative fuels/additives (2-5%) and reduced lead distance (by 6%). Increased utilisation also resulted in operating leverage gains and as a result other expenses per MT fell 7% YoY and 9% QoQ. Employee cost fell 9% QoQ owing to a fall in gratuity provisioning (yield hardening impact). Unitary EBITDA up 2% YoY to Rs922: Higher realisation and utilisation YoY and rising cost controls more than offset input cost increase, leading to marginal increase in unitary EBITDA. Thus, EBITDA rose 33% YoY. Higher capital charges YoY moderated PAT growth to 2% YoY. On-going expansions to bolster UTCEM s market share gain; Reiterate BUY: UTCEM s ongoing ramp-up of JPA s assets, its upcoming expansions in UP, MP and Rajasthan during FY19-20, should further bolster UTCEM 13% volume CAGR during FY18-20 (on 21% growth in FY18). We model in 7% organic volume CAGR during FY17-20E and the rest of the growth should come from JPA s capacity ramp-up to 80% by FY20 (on 21 mn MT). We estimate good demand to boost industry utilisation and hence model in 4% NSR increase for UTCEM. Also, better pricing and increased utilisation should drive margin expansion. We trim FY19/20E EBITDA estimates by 4%/3% respectively to account for ongoing increase seen in fuel and diesel prices. We continue to like UltraTech owing to its industry leadership, prudent cost structure, and steady capacity growth without straining its balance sheet. We reiterate BUY with a revised TP of Rs4980 (15x FY20E EBIDTA). Y/E Mar (Rs mn) Q4FY18 Q4FY17 YoY (%) Q3FY18 QoQ (%) Q4FY18E Variance % Net Sales 90,025 65, , , Op. cost 72,997 53, , ,047 (0.1) EBITDA 17,028 12, , , EBITDA margin (%) (47) Depreciation 4,806 3, , , Interest 3,348 1, ,472 (3.6) 3,500 (4.4) Other Income 1,059 2,401 (55.9) 1,556 (31.9) 1,550 (31.7) PBT 9,934 10,297 (3.5) 6, , Taxes Paid 2,791 3,276 (14.8) 1, , Adjusted PAT 7,142 7, , , Source: Company, Centrum Research Estimate, Standalone Financials Target Price Rs4,980 Key Data CMP* Rs4,135 Bloomberg Code UTCEM IN Upside 20% Curr Shares O/S (mn) Previous Target Rs5,140 Diluted Shares O/S(mn) Previous Rating BUY Mkt Cap (Rsbn/USDbn) /17 Price Performance (%)* 52 Wk H / L (Rs) 4600/3773 1M 6M 1Yr 5 Year H / L (Rs) 4600/1402 UTCEM IN 6.7 (7.3) (2.5) Daily Vol. (3M NSE Avg.) 209,136 NIFTY *as on 25 April 2018; Source: Bloomberg, Centrum Research Shareholding pattern (%)* Mar -18 Dec -17 Sep -17 Jun -17 Promoter FIIs Dom. Inst Public & Others Source: BSE, *as on 25 April 2018 Operational Trends Sales vol (mn MT) Rs/ MT trends Q4FY18 Q4FY17 YoY (%) Q3FY18 QoQ (%) NSR 4,874 4, , Raw materials (2.1) 840 (4.7) Power & fuel 1, Freight 1,232 1, , Employee (7.4) 292 (22.3) Other Exp (6.6) 728 (8.6) Opex 3,952 3, ,988 (0.9) EBITDA Source: Company, Centrum Research Earning Revisions summary Particulars (Rs bn) FY19E FY20E New Old Chg (%) New Old Chg (%) Sales EBITDA (4.2) (2.9) Ebitda margin (%) Adj PAT (6.2) (3.5) Source: Centrum Research Estimates Centrum vs. Bloomberg Consensus* Particulars (Rs bn) FY19E FY20E Centrum BBG Var (%) Centrum BBG Var (%) Net Sales EBITDA PAT Bloomberg Consensus* BUY SELL HOLD Target Price (Rs) Centrum Target Price (Rs) Variance (%) , Source: Bloomberg, Centrum Research Estimates; *as on 25 April 2018 Rajesh Kumar Ravi, rajesh.ravi@centrum.co.in; Vinay Menon, vinay.menon@centrum.co.in; Y/E Mar (Rs mn) Revenue YoY (%) EBITDA EBITDA (%) APAT YoY (%) DEPS Rs. RoE (%) RoCE (%) P/E (x) EV/EBITDA (x) FY16 2,37, , , FY17 2,38, , , FY18 2,97, , ,576 (7.0) FY19E 3,60, , , FY20E 4,14, , , Source: Company, Centrum Research Estimates, Standalone Financials Centrum Equity Research is available on Bloomberg, Thomson Reuters and FactSet

2 Key operational highlights and other details from the concall As per the company presentation, cement sales has been strong YoY across most markets in Q4FY18. Infrastructure construction and a low cost housing demand has contributed mainly to the robust industry growth in Q4FY18. UTCEM s standalone total sales volume rose 31% YoY (+17% QoQ) to 18.5mn MT. Grey sales volume rose 32% YoY and (+16% QoQ) to 18.1 mn MT. White cement/putty volume rose 4% YoY at 0.4mn MT (+21% QoQ). The JPA plants contributed ~3.2mn MT to the total sales volume which implies UltraTech (ex-jpa plant) delivered ~8% volume growth YoY. Company s ex-jpa capacity utilisation increased to 90% vs 83% YoY and vs 79% QoQ. UTCEM operated the JPA units at ~75% utilisation in Q4FY18 and is confident of a higher ramp-up in subsequent quarters (~85% in Q1FY19E). Higher than estimated ramp-up of JPA assets led to cash-break-even in Q4FY18 (1 quarter ahead of management expectations). UTCEM guided that JPA asset will become PBT break-even by Q1FY20. During Q4FY18, JPA units opex were higher by ~Rs200/MT that of UTCEM. Out of this, ~ Rs64/MT is on account of higher royalty which will continue going forward. UTCEM is hopeful to bridge the residual cost gap over next the 1-2 quarters through ongoing process improvement projects. The management highlighted its regional utilisation as follows: North (88% vs 80% QoQ), Central (76% vs 60% QoQ), East (90% vs 80% QoQ), West (82% vs 70% QoQ) and South (70% vs 53% QoQ). This implies that UTCEM registered 25%+ QoQ production growth in its central and southern plants. Amid strong growth in grey cement sales, the share of white cement/putty and RMC revenue fell to 6% and 6% of total revenue in Q4FY18 vs 8% and 7% respectively YoY. UltraTech noted that rural markets accounted for ~40% of overall sales. The share has been maintained over the past three quarters. UTCEM s reported energy cost rose 17% YoY and 4% QoQ to Rs987/MT. Average cost of pet-coke for Q4FY18 rose 0% QoQ and 22% YoY to USD104/MT. With ban on pet-coke for captive power generation, company consumed coal leading to higher cost QoQ. UTCEM s logistics cost rose 6% YoY to Rs1,166/MT mainly on account of an increase in diesel prices and increased FOR based sales. On QoQ basis, its logistics cost is up 4% as a result of high diesel prices. Exhibit 1: Energy cost trends Power Mix Q2 FY16 Q3 FY16 Q4 FY16 Q1FY17 Q2FY17 Q3FY17 Q4FY17 Q1FY18 Q2FY18 Q3FY18 Q4FY18 TPP + WHRS (% of total) N/A N/A N/A N/A N/A N/A Kiln Fuel Mix (%) Pet coke Imp coal NA Indigenous coal and others NA Energy costs (Rs/MT) QoQ (%) 0.9 (9.4) (16.9) (0.4) YoY (%) (10.6) (17.1) (27.1) (24.3) (18.9) (4.7) Source: Company, Centrum Research, N/A- data not available 2

3 Exhibit 2: Transport mix and logistics cost trend Q2 FY16 Q3 FY16 Q4 FY16 Q1 FY17 Q2 FY17 Q3 FY17 Q4 FY17 Q1FY18 Q2 FY18 Q3 FY18 Q4 FY18 Freight Mix (%) Rail NA Road NA Sea NA Logistics cost (Rs/MT) 1,089 1,089 1,088 1,081 1,041 1,060 1,104 1,098 1,089 1,127 1,166 QoQ (%) 3.2 (3.6) (0.1) (0.6) (3.7) (0.5) (0.8) YoY (%) 11.4 (1.1) (0.6) (4.3) (4.4) (2.7) Source: Company, Centrum Research UTCEM reported QoQ reduction in net debt by Rs10bn and a working capital release of Rs4.65bn QoQ. Net debt/ebitda improved from 2.1x in Q2FY18 to 1.85x in Q4FY18. Capex updates UTCEM s green-field expansion of 3.5mn MT at Dhar, MP is ahead of schedule. It commissioned 1.75 mn MT in April 2018 with the remainder expected by Sep The pending Bara grinding unit is expected to be commissioned in Q1FY20. The 3.5mn MT grey cement expansion in Pali, Rajasthan is expected to be completed in FY20 (capex ~Rs18.5bn). Post these, UTCEM s India capacity will increase to 87mn MT/ 95mn MT by end of FY19/ FY20. UTCEM is also working on0.4mn MT of white putty plant expansion project, to be completed by Q2FY20. This would entail capex of Rs2bn. Post this expansion, its white/putty capacity will increase to 1.72 mnmt. 3

4 Valuation and operational assumptions Exhibit 3: 1-yr forward EV/EBITDA chart Exhibit 4: 1-yr forward EV/MT chart Apr-06 Apr-07 Apr-08 Apr-09 Apr-10 Apr-11 Apr-12 Apr-13 Apr-14 Apr-15 Apr-16 Apr-17 Apr Apr-11 Apr-12 Apr-13 Apr-14 Apr-15 Apr-16 Apr-17 Apr-18 EV/EBITDA Mean EV/MT Mean Mean + 1 Std Dev Mean - 1 Std Dev Mean + 1 Std Dev Mean - 1 Std Dev Source: Bloomberg, Company, Centrum Research Estimates Source: Bloomberg, Company, Centrum Research Estimates Exhibit 5: Comparative Valuations Company Mkt Cap (Rs bn) CAGR FY18-20E (%) EBITDA margin (%) RoCE (%) RoE (%) EV/EBITDA (x) EV/MT(USD) Rev. EBITDA PAT FY18 FY19E FY20E FY18 FY19E FY20E FY18 FY19E FY20E FY18 FY19E FY20E FY18 FY19E FY20E ACC Ambuja Cements Shree Cement ** (9.3) Source: Company, Centrum Research Estimates, For ACC/ Ambuja FY17/18/19 = CY16/17/18, Shree Cement FY18 numbers are estimates 4

5 Exhibit 6: Key Operational Assumptions Particulars FY15 FY16 FY17 FY18 FY19E FY20E Total Cement capacity (mn MT) Total Sales Volume (mn MT) YoY change (%) Capacity utilisation (%) (Rs/ MT trend) Blended NSR 4,976 4,812 4,761 4,911 5,124 5,333 YoY change (%) 4.6 (3.3) (1.1) Raw Materials Power & Fuel 1, ,032 1,063 Freight costs 1,171 1,204 1,165 1,208 1,243 1,275 Employee cost Other expense Total Opex 4,066 3,873 3,771 3,941 4,033 4,121 EBITDA per MT ,091 1,211 Source: Company, Centrum Research Estimates 5

6 Exhibit 7: Quarterly financials trend (Standalone) Y/E Mar (Rs mn) Q1FY17 Q2FY17 Q3FY17 Q4FY17 Q1FY18 Q2FY18 Q3FY18 Q4FY18 Net Sales 62,325 54,576 56,091 65,953 66,265 65,713 75,899 90,025 Total Expenditure 48,100 43,028 44,956 53,171 50,664 52,200 63,207 72,997 Raw Materials 10,924 8,609 9,236 11,508 9,547 9,153 13,310 14,786 Power and Fuel 9,237 8,797 9,689 11,543 12,174 13,348 15,093 18,980 Employee 3,466 3,572 3,647 3,449 3,803 4,440 4,628 4,192 Transport 15,452 12,749 13,606 16,645 15,880 15,553 18,634 22,750 Others 9,021 9,301 8,779 10,027 9,261 9,707 11,541 12,289 EBITDA 14,225 11,548 11,135 12,782 15,601 13,513 12,691 17,028 Depreciation 3,027 3,139 3,156 3,357 3,098 4,988 4,744 4,806 EBIT 11,198 8,409 7,978 9,425 12,503 8,525 7,947 12,222 Interest 1,525 1,367 1,293 1,529 1,285 3,759 3,472 3,348 Other Income 1,504 1, ,401 1,652 1,680 1,556 1,059 PBT 11,177 8,767 7,655 10,297 12,870 6,447 6,031 9,934 Taxes 3,428 2,757 2,021 3,276 3,963 2,135 1,816 2,791 Exceptional expense/ (income) (173) (179) (75) (93) 0 (2,263) Reported PAT 7,576 6,123 5,678 6,842 8,832 4,220 4,215 4,879 Adjusted PAT 7,749 6,011 5,634 7,020 8,906 4,312 4,215 7,142 Adj EPS (Rs) YoY Growth (%) Sales volume (1.3) 0.8 (0.2) Cement NSR (2.5) (2.8) (0.8) Revenue 3.8 (2.3) (2.1) EBITDA (0.1) (7.2) PBT (2.2) 15.1 (26.5) (21.2) (3.5) Adj PAT (10.1) 14.9 (28.3) (25.2) 1.7 Margins (%) EBITDA EBIT PBT Adj PAT Operational Trend Cement & clinker Sales Vol (mn MT) Trends (Rs/mt) NSR 4,720 4,882 4,782 4,687 5,026 5,001 4,788 4,874 Raw material cost Power and fuel cost , ,028 Employee cost Transport cost 1,170 1,140 1,160 1,183 1,204 1,184 1,176 1,232 Other expenses Operating cost 3,643 3,849 3,833 3,779 3,843 3,973 3,988 3,952 EBITDA per MT 1,077 1, ,183 1, Source: Company, Centrum Research 6

7 Financials (Standalone) Exhibit 8: Income Statement Y/E March (Rsmn) FY16 FY17 FY18 FY19E FY20E Revenues 2,37,143 2,38,915 2,97,901 3,60,031 4,14,239 Materials cost 39,906 39,514 46,797 55,701 62,860 % of revenues Employee Cost 13,430 14,134 17,066 19,674 21,750 % of revenues Others 1,37,541 1,35,577 1,75,205 2,07,973 2,35,529 % of revenues EBITDA 46,266 49,690 58,833 76,683 94,100 EBIDTA Margins (%) Depreciation & Amortisation 12,970 12,679 17,636 21,784 23,434 EBIT 33,296 37,011 41,198 54,899 70,666 Interest expenses 5,117 5,714 11,863 13,277 9,622 PBT from operations 28,179 31,297 29,335 41,623 61,045 Other Income 4,807 6,600 5,947 6,224 6,790 Exceptional loss/(gain) 26 (333) (2,263) - - PBT 33,012 37,564 33,019 47,847 67,835 Taxes 9,284 11,482 10,706 14,832 21,029 Effective tax rate (%) Net Profit 23,728 26,081 22,313 33,014 46,806 Reported Net Profit 23,728 26,081 22,313 33,014 46,806 Adj Net Profit 23,702 26,414 24,576 33,014 46,806 Source: Company, Centrum Research Estimates Exhibit 9: Key Ratios Y/E March FY16 FY17 FY18P FY19E FY20E Growth ratios (%) Revenues EBIDTA Adj Net Profit (7.0) Margin ratios (%) EBITDA Margin PBT from operations Margin Adj PAT Margin Return Ratios (%) RoE RoCE RoIC Turnover Ratios (days) Gross block turnover (x) Debtors Inventory Creditors Cash conversion cycle Solvency Ratio Net debt-equity 0.0 (0.1) Debt-equity Interest coverage ratio Gross debt/ebitda Current Ratio Per Share (Rs) Adjusted EPS BVPS , ,210.1 CEPS DPS Dividend payout % Valuations (x)(avg Mkt Cap) P/E (adjusted) P/BV EV/EBITDA EV/ton (USD $) Dividend yield % Yr Avg AOCF/EV yield % Source: Company, Centrum Research Estimates Exhibit 10: Balance Sheet Y/E March (Rsmn) FY16 FY17 FY18 FY19E FY20E Equity Share Capital 2,744 2,745 2,746 2,746 2,746 Reserves & surplus 2,13,574 2,36,665 2,56,486 2,86,289 3,29,561 Total Shareholders' Fund 2,16,318 2,39,410 2,59,232 2,89,035 3,32,307 Total Debt 82,496 62,404 1,74,195 1,38,195 88,195 Def tax liab. (net) 24,320 27,736 31,741 31,741 31,741 Total Liabilities 3,23,134 3,29,550 4,65,168 4,58,971 4,52,243 Gross Block 2,39,127 2,56,747 4,14,179 4,57,179 4,80,179 Less:- Accumulated Depreciation 12,241 24,424 42,059 63,843 87,277 Net Block 2,26,886 2,32,324 3,72,120 3,93,336 3,92,902 Capital WIP 14,145 8,778 14,730 (3,270) 1,730 Net Fixed assets 2,41,031 2,41,101 3,86,850 3,90,066 3,94,632 Investments 57,932 74,087 61,629 51,629 51,629 Inventories 22,776 22,250 31,015 35,510 39,722 Sundry Debtors 14,149 12,762 17,142 19,728 22,131 Cash & bank balances 22,352 22,177 1,993 1,713 1,141 Loans & Advances 10,372 5,390 6,364 6,905 7,944 Other Assets 14,294 15,044 38,740 39,455 34,047 Total current assets 83,943 77,623 95,254 1,03,311 1,04,985 Trade payables 15,815 17,138 23,435 22,290 25,185 Other current liabilities 39,811 41,821 48,908 57,043 66,564 Provisions 4,146 4,302 6,221 6,702 7,254 Net current assets 24,171 14,362 16,689 17,276 5,982 Total 3,23,134 3,29,550 4,65,168 4,58,971 4,52,243 Source: Company, Centrum Research Estimates Exhibit 11: Cash Flow Y/E March (Rsmn) FY16 FY17 FY18E FY19E FY20E Op profit before WC changes 38,333 42,334 52,132 61,851 73,071 Working capital changes 5,211 4,878 (2,512) (867) 10,723 Cash from Operations 43,544 47,213 49,621 60,984 83,794 Adj. OCF (OCF-Interest) 38,156 41,742 37,758 47,707 74,173 Net capex (20,595) (12,316) (65,814) (25,000) (28,000) Adj. FCF (AOCF-Capex) 17,561 29,426 (28,057) 22,707 46,173 Cash from investing (37,567) (23,635) (47,410) (8,776) (21,210) Cash from financing (5,824) (23,826) (23,445) (52,488) (63,156) Net change in cash 153 (249) (21,234) (280) (571) Source: Company, Centrum Research Estimates 7

8 Appendix A Disclaimer Centrum Broking Limited ( Centrum ) is a full-service, Stock Broking Company and a member of The Stock Exchange, Mumbai (BSE) and National Stock Exchange of India Ltd. (NSE). Our holding company, Centrum Capital Ltd, is an investment banker and an underwriter of securities. As a group Centrum has Investment Banking, Advisory and other business relationships with a significant percentage of the companies covered by our Research Group. Our research professionals provide important inputs into the Group's Investment Banking and other business selection processes. Recipients of this report should assume that our Group is seeking or may seek or will seek Investment Banking, advisory, project finance or other businesses and may receive commission, brokerage, fees or other compensation from the company or companies that are the subject of this material/report. Our Company and Group companies and their officers, directors and employees, including the analysts and others involved in the preparation or issuance of this material and their dependants, may on the date of this report or from, time to time have "long" or "short" positions in, act as principal in, and buy or sell the securities or derivatives thereof of companies mentioned herein. Centrum or its affiliates do not own 1% or more in the equity of this company Our sales people, dealers, traders and other professionals may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. We may have earlier issued or may issue in future reports on the companies covered herein with recommendations/ information inconsistent or different those made in this report. In reviewing this document, you should be aware that any or all of the foregoing, among other things, may give rise to or potential conflicts of interest. We and our Group may rely on information barriers, such as "Chinese Walls" to control the flow of information contained in one or more areas within us, or other areas, units, groups or affiliates of Centrum. Centrum or its affiliates do not make a market in the security of the company for which this report or any report was written. Further, Centrum or its affiliates did not make a market in the subject company s securities at the time that the research report was published. This report is for information purposes only and this document/material should not be construed as an offer to sell or the solicitation of an offer to buy, purchase or subscribe to any securities, and neither this document nor anything contained herein shall form the basis of or be relied upon in connection with any contract or commitment whatsoever. This document does not solicit any action based on the material contained herein. It is for the general information of the clients of Centrum. Though disseminated to clients simultaneously, not all clients may receive this report at the same time. Centrum will not treat recipients as clients by virtue of their receiving this report. It does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. Similarly, this document does not have regard to the specific investment objectives, financial situation/circumstances and the particular needs of any specific person who may receive this document. The securities discussed in this report may not be suitable for all investors. The securities described herein may not be eligible for sale in all jurisdictions or to all categories of investors. The countries in which the companies mentioned in this report are organized may have restrictions on investments, voting rights or dealings in securities by nationals of other countries. The appropriateness of a particular investment or strategy will depend on an investor's individual circumstances and objectives. Persons who may receive this document should consider and independently evaluate whether it is suitable for his/ her/their particular circumstances and, if necessary, seek professional/financial advice. Any such person shall be responsible for conducting his/her/their own investigation and analysis of the information contained or referred to in this document and of evaluating the merits and risks involved in the securities forming the subject matter of this document. The projections and forecasts described in this report were based upon a number of estimates and assumptions and are inherently subject to significant uncertainties and contingencies. Projections and forecasts are necessarily speculative in nature, and it can be expected that one or more of the estimates on which the projections and forecasts were based will not materialize or will vary significantly from actual results, and such variances will likely increase over time. All projections and forecasts described in this report have been prepared solely by the authors of this report independently of the Company. These projections and forecasts were not prepared with a view toward compliance with published guidelines or generally accepted accounting principles. No independent accountants have expressed an opinion or any other form of assurance on these projections or forecasts. You should not regard the inclusion of the projections and forecasts described herein as a representation or warranty by or on behalf of the Company, Centrum, the authors of this report or any other person that these projections or forecasts or their underlying assumptions will be achieved. For these reasons, you should only consider the projections and forecasts described in this report after carefully evaluating all of the information in this report, including the assumptions underlying such projections and forecasts. The price and value of the investments referred to in this document/material and the income from them may go down as well as up, and investors may realize losses on any investments. Past performance is not a guide for future performance. Future returns are not guaranteed and a loss of original capital may occur. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and may be subject to change without notice. Centrum does not provide tax advice to its clients, and all investors are strongly advised to consult regarding any potential investment. Centrum and its affiliates accept no liabilities for any loss or damage of any kind arising out of the use of this report. Foreign currencies denominated securities are subject to fluctuations in exchange rates that could have an adverse effect on the value or price of or income derived from the investment. In addition, investors in securities such as ADRs, the value of which are influenced by foreign currencies effectively assume currency risk. Certain transactions including those involving futures, options, and other derivatives as well as non-investment-grade securities give rise to substantial risk and are not suitable for all investors. Please ensure that you have read and understood the current risk disclosure documents before entering into any derivative transactions. This report/document has been prepared by Centrum, based upon information available to the public and sources, believed to be reliable. No representation or warranty, express or implied is made that it is accurate or complete. Centrum has reviewed the report and, in so far as it includes current or historical information, it is believed to be reliable, although its accuracy and completeness cannot be guaranteed. The opinions expressed in this document/material are subject to change without notice and have no obligation to tell you when opinions or information in this report change. This report or recommendations or information contained herein do/does not constitute or purport to constitute investment advice in publicly accessible media and should not be reproduced, transmitted or published by the recipient. The report is for the use and consumption of the recipient only. This publication may not be distributed to the public used by the public media without the express written consent of Centrum. This report or any portion hereof may not be printed, sold or distributed without the written consent of Centrum. The distribution of this document in other jurisdictions may be restricted by law, and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Neither Centrum nor its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profits that may arise from or in connection with the use of the information. This document does not constitute an offer or invitation to subscribe for or purchase or deal in any securities and neither this document nor anything contained herein shall form the basis of any contract or commitment whatsoever. This document is strictly confidential and is being furnished to you solely for your information, may not be distributed to the press or other media and may not be reproduced or redistributed to any other person. The distribution of this report in other jurisdictions may be restricted by law and persons into whose possession this report comes should inform themselves about, and observe any such restrictions. By accepting this report, you agree to be bound by the fore going limitations. No representation is made that this report is accurate or complete. 8

9 The opinions and projections expressed herein are entirely those of the author and are given as part of the normal research activity of Centrum Broking and are given as of this date and are subject to change without notice. Any opinion estimate or projection herein constitutes a view as of the date of this report and there can be no assurance that future results or events will be consistent with any such opinions, estimate or projection. This document has not been prepared by or in conjunction with or on behalf of or at the instigation of, or by arrangement with the company or any of its directors or any other person. Information in this document must not be relied upon as having been authorized or approved by the company or its directors or any other person. Any opinions and projections contained herein are entirely those of the authors. None of the company or its directors or any other person accepts any liability whatsoever for any loss arising from any use of this document or its contents or otherwise arising in connection therewith. Centrum and its affiliates have not managed or co-managed a public offering for the subject company in the preceding twelve months. Centrum and affiliates have not received compensation from the companies mentioned in the report during the period preceding twelve months from the date of this report for service in respect of public offerings, corporate finance, debt restructuring, investment banking or other advisory services in a merger/acquisition or some other sort of specific transaction. As per the declarations given by them, Mr. Rajesh Kumar Ravi, & Mr. Vinay Menon, research analyst and and/or any of their family members do not serve as an officer, director or any way connected to the company/companies mentioned in this report. Further, as declared by them, they are not received any compensation from the above companies in the preceding twelve months. They do not hold any shares by them or through their relatives or in case if holds the shares then will not to do any transactions in the said scrip for 30 days from the date of release such report. Our entire research professionals are our employees and are paid a salary. They do not have any other material conflict of interest of the research analyst or member of which the research analyst knows of has reason to know at the time of publication of the research report or at the time of the public appearance. While we would endeavour to update the information herein on a reasonable basis, Centrum, its associated companies, their directors and employees are under no obligation to update or keep the information current. Also, there may be regulatory, compliance or other reasons that may prevent Centrum from doing so. Non-rated securities indicate that rating on a particular security has been suspended temporarily and such suspension is in compliance with applicable regulations and/or Centrum policies, in circumstances where Centrum is acting in an advisory capacity to this company, or any certain other circumstances. This report is not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would subject Centrum Broking Limited or its group companies to any registration or licensing requirement within such jurisdiction. Specifically, this document does not constitute an offer to or solicitation to any U.S. person for the purchase or sale of any financial instrument or as an official confirmation of any transaction to any U.S. person unless otherwise stated, this message should not be construed as official confirmation of any transaction. No part of this document may be distributed in Canada or used by private customers in United Kingdom. The information contained herein is not intended for publication or distribution or circulation in any manner whatsoever and any unauthorized reading, dissemination, distribution or copying of this communication is prohibited unless otherwise expressly authorized. Please ensure that you have read Risk Disclosure Document for Capital Market and Derivatives Segments as prescribed by Securities and Exchange Board of India before investing in Indian Securities Market. Ultratech Cement price chart Apr-15 Oct-15 Apr-16 Oct-16 Apr-17 Oct-17 Apr-18 Ultratech Cement Source: Bloomberg, Centrum Research 9

10 1 2 Business activities of Centrum Broking Limited (CBL) Details of Disciplinary History of CBL Disclosure of Interest Statement Centrum Broking Limited (hereinafter referred to as CBL ) is a registered member of NSE (Cash, F&O and Currency Derivatives Segments), MCX-SX (Currency Derivatives Segment) and BSE (Cash segment), Depository Participant of CDSL and a SEBI registered Portfolio Manager. CBL has not been debarred/ suspended by SEBI or any other regulatory authority from accessing /dealing in securities market. 3 Registration status of CBL: CBL is registered with SEBI as a Research Analyst (SEBI Registration No. INH ) 4 5 Whether Research analyst s or relatives have any financial interest in the subject company and nature of such financial interest Whether Research analyst or relatives have actual / beneficial ownership of 1% or more in securities of the subject company at the end of the month immediately preceding the date of publication of the document. Ultratech ACC Ambuja Cements Shree Cement 6 Whether the research analyst or his relatives has any other material conflict of interest Whether research analyst has received any compensation from the subject company in the past 12 months and nature of products / services for which such compensation is received Whether the Research Analyst has received any compensation or any other benefits from the subject company or third party in connection with the research report Whether Research Analysts has served as an officer, director or employee of the subject company Whether the Research Analyst has been engaged in market making activity of the subject company. Rating Criteria Rating Market cap < Rs20bn Market cap > Rs20bn but < 100bn Market cap > Rs100bn Buy Upside > 20% Upside > 15% Upside > 10% Hold Upside between -20% to +20% Upside between -15% to +15% Upside between -10% to +10% Sell Downside > 20% Downside > 15% Downside > 10% Member (NSE and BSE) Regn No.: CAPITAL MARKET SEBI REGN. NO.: BSE: INB CAPITAL MARKET SEBI REGN. NO.: NSE: INB DERIVATIVES SEBI REGN. NO.: NSE: INF (TRADING & CLEARING MEMBER) CURRENCY DERIVATIVES: MCX-SX INE CURRENCY DERIVATIVES:NSE (TM & SCM) NSE Depository Participant (DP) CDSL DP ID: SEBI REGD NO. : CDSL : IN-DP-CDSL PORTFOLIO MANAGER SEBI REGN NO.: INP Website: Investor Grievance ID: investor.grievances@centrum.co.in Compliance Officer Details: Kavita Ravichandran (022) ; ID: compliance@centrum.co.in Centrum Broking Ltd. (CIN :U67120MH1994PLC078125) Registered Office Address Bombay Mutual Building, 2nd Floor, Dr. D. N. Road, Fort, Mumbai Corporate Office & Correspondence Address Centrum House 6th Floor, CST Road, Near Vidya Nagari Marg, Kalina, Santacruz (E), Mumbai Tel: (022)

UltraTech Cement BUY. Robust volume growth offsets cost pressure INDIA. Cement. Result Update 18 January 2018

UltraTech Cement BUY. Robust volume growth offsets cost pressure INDIA. Cement. Result Update 18 January 2018 INDIA BUY Result Update 18 January 2018 Cement Robust volume growth offsets cost pressure UltraTech s (UTCEM) Q3FY18 standalone EBITDA rose 14% YoY buoyed by 35% YoY volume growth (core volume up 14% YoY)

More information

UltraTech Cement HOLD

UltraTech Cement HOLD INDIA HOLD Result Update 26 April 2017 Cement Cost efficiencies moderate rising input cost impact UltraTech s (UTCEM) Q4FY17 standalone EBITDA dipped 7% YoY led by muted volume and price growth amid higher

More information

Graphite India Ltd. Hold. Margins dip due to weak realizations; maintain hold INDIA. Metals

Graphite India Ltd. Hold. Margins dip due to weak realizations; maintain hold INDIA. Metals INDIA Metals Result Update 12 May 2014 Hold Margins dip due to weak realizations; maintain hold We maintain Hold rating on (GIL) with a target price of Rs93 as operating environment remains challenging

More information

FIEM Industries BUY. Robust auto segment performance continues, Maintain Buy INDIA. Automobiles. Result Update 31 May 2018

FIEM Industries BUY. Robust auto segment performance continues, Maintain Buy INDIA. Automobiles. Result Update 31 May 2018 INDIA BUY Result Update 31 May 2018 Automobiles Robust auto segment performance continues, Maintain Buy We maintain our Buy rating on with TP of Rs1,249. We expect FIEM s growth to continue aided by strong

More information

Centrum Wealth Research is also available on Bloomberg: CBWM <GO>, Thomson Reuters, Capital IQ and Factset

Centrum Wealth Research is also available on Bloomberg: CBWM <GO>, Thomson Reuters, Capital IQ and Factset May-17 Jul-17 Sep-17 v-17 Jan-18 Mar-18 May-18 May 23, 2018 Q4FY18 Result Update Growth to pick-up along with better recoveries (MFL) reported mixed results. Net interest income (NII) grew at the slowest

More information

Centrum Wealth Research is also available on Bloomberg: CBWM <GO>, Thomson Reuters, Capital IQ and Factset

Centrum Wealth Research is also available on Bloomberg: CBWM <GO>, Thomson Reuters, Capital IQ and Factset vember 21, 2017 Q2FY18 Result Update Ahluwalia Contracts (India) Ltd Good quarter, order inflows gathering momentum Ahluwalia Contracts (India) Ltd (ACIL), for Q2FY18, reported good numbers. Revenue grew

More information

Orient Cement SELL. A bad quarter gone by; return ratios to remain subdued INDIA. Cement. Rating Revision 11 November 2016

Orient Cement SELL. A bad quarter gone by; return ratios to remain subdued INDIA. Cement. Rating Revision 11 November 2016 INDIA SELL Rating Revision 11 November 2016 Cement A bad quarter gone by; return ratios to remain subdued We downgrade ORCMNT to SELL from HOLD with a revised TP of Rs100 (earlier TP Rs180). Its Q2FY17

More information

Result Update 15 Novmeber 2016

Result Update 15 Novmeber 2016 INDIA BUY Result Update 15 vmeber 2016 Automobiles In-line quarter; Maintain Buy FIEM reported 2QFY17 PAT of Rs141mn. While the revenues were marginally ahead of our estimates, EBITDA at Rs360mn came in

More information

Result Update 26 February 2018

Result Update 26 February 2018 INDIA HOLD Result Update 26 February 2018 Pharma Chemical segment to drive profitability; maintain Hold We maintain our Hold rating on with TP to Rs1,290 (earlier Rs1,080) based on 16x December 19E EPS

More information

Centrum Wealth Research is also available on Bloomberg: CBWM <GO>, Thomson Reuters, Capital IQ and Factset

Centrum Wealth Research is also available on Bloomberg: CBWM <GO>, Thomson Reuters, Capital IQ and Factset vember 17, 2016 Q2FY17 Result Update Jain Irrigation Systems Ltd Better prospects in the long term Jain Irrigation Systems Ltd (JISL) for Q2FY17 on a consolidated basis reported decent results for the

More information

Result update 10 November 2016

Result update 10 November 2016 INDIA BUY Result update 10 November 2016 Pharma Key brands to drive growth, maintain Buy We maintain Buy rating for, with a TP of Rs270 (earlier Rs240) based on 17x March 18E EPS of Rs15.6, as its major

More information

Rating Revision 17 November 2016

Rating Revision 17 November 2016 INDIA HOLD Rating Revision 17 vember 2016 Pharma Regulatory pain continues, downgrade to Hold We downgrade (MPL) to Hold from Buy rating, with a TP of Rs36 (earlier Rs60) based on 18x March 18E EPS of

More information

EBITDA 5,076 3, , EBITDA

EBITDA 5,076 3, , EBITDA Result Update Ambuja Cements 21 February 218 Reuters: ABUJ.BO; Bloomberg: ACEM IN Healthy Volume Growth, Operating Costs Under Control Ambuja Cements (ACEM) reported a good set of numbers for owing to

More information

Centrum Wealth Research is also available on Bloomberg: CBWM <GO>, Thomson Reuters, Capital IQ and Factset

Centrum Wealth Research is also available on Bloomberg: CBWM <GO>, Thomson Reuters, Capital IQ and Factset March 1, 2018 Q3FY18 Result Update Jain Irrigation Systems Ltd Good quarter, business momentum gaining traction Jain Irrigation Systems Ltd (JISL), for Q3FY18 on a consolidated basis, reported good numbers.

More information

Dalmia Bharat Enterprises

Dalmia Bharat Enterprises Result Update Dalmia Bharat Enterprises 1 November 218 Reuters: DALA.BO; Bloomberg: DBEL IN Performance In Line; Stock Under Review Post Odisha Cement Amalgamation Dalmia Bharat Enterprises (DBEL) reported

More information

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights JK 20 NOV 2017 Quarterly Update BUY Target Price: Rs 1,220 White cement steals the show JK Cement s (JKCE) Q2FY18 EBITDA at Rs 2.1 bn (up 30% YoY) was higher than our and consensus estimates, mainly due

More information

ACC BUY. Performance Highlights. CMP `1,397 Target Price `1,630. 3QCY2015 Result Update Cement

ACC BUY. Performance Highlights. CMP `1,397 Target Price `1,630. 3QCY2015 Result Update Cement 3QCY2015 Result Update Cement October 27, 2015 ACC Performance Highlights Quarterly results (Standalone) Y/E Dec (` cr) 3QCY2015 2QCY2015 % chg qoq 3QCY2014 % chg yoy Net revenue 2,740 2,961 (7.5) 2,742

More information

Mangalam Cement. Institutional Equities. 3QFY18 Result Update. Higher Operating costs Hurt Performance BUY

Mangalam Cement. Institutional Equities. 3QFY18 Result Update. Higher Operating costs Hurt Performance BUY Result Update Mangalam Cement 16 February 2018 Reuters: MGLC.BO; Bloomberg: MGC IN Higher Operating costs Hurt Performance Mangalam Cement (MGC) reported a weak performance for on account of higher operating

More information

Visaka Industries Ltd

Visaka Industries Ltd Company Update Superior Product Mix & New Age Markets to Aid Growth New investments to aid growth: Visaka continues to give a good set of numbers. YoY EPS grew at 142% aided by a revenue growth of 1.5%

More information

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months 2QFY2019 Result Update Industrial Machinery October 26, 2018 GMM Pfaudler Limited Performance Update Standalone (` cr) Q2FY19 Q2FY18 % yoy Q1FY19 % qoq Net sales 99.2 93.2 29.8% 76.4 6.4% EBITDA 16.0 15.3

More information

EBITDA 6,223 6,511 (4.4) 5, EBITDA

EBITDA 6,223 6,511 (4.4) 5, EBITDA Result Update Institutional Equities Ambuja Cements 26 July 218 Reuters: ABUJ.BO; Bloomberg: ACEM IN Performance Beats Expectations, Sustainability Is Key Challenge Ambuja Cements (ACEM) reported steady

More information

Vadodara II PPA yet to be signed; TP revised upward to Rs126 on FY19x

Vadodara II PPA yet to be signed; TP revised upward to Rs126 on FY19x Gujarat Industries Power India Equity Research Power February 10, 2017 Result Update Emkay Your success is our success Vadodara II PPA yet to be signed; TP revised upward to Rs126 on FY19x CMP Target Price

More information

Symphony Ltd. RESULT UPDATE 31st October 2017

Symphony Ltd. RESULT UPDATE 31st October 2017 . RESULT UPDATE 31st October 2017 Oct-14 Apr-15 Oct-15 Apr-16 Oct-16 Apr-17 Oct-17 India Equity Institutional Research II Result Update Q2FY18 II 31st October 2017. CMP INR 1,465 Target INR 1,700 Potential

More information

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E RAMCO S BUY Target Price: Rs 435 Efforts on cost cutting paying off Q2 EBITDA at Rs 2.8 bn (up 30% YoY) was ahead of our estimates due to lower-than-expected costs. Average costs (excluding freight) declined

More information

EBITDA 5,019 4,211 5, EBITDA

EBITDA 5,019 4,211 5, EBITDA Result Update Institutional Equities Dalmia Bharat Reuters: DALA.BO; Bloomberg: DBEL IN Outperformance Likely To Continue Dalmia Bharat (DBL) reported a good set of numbers for, given the challenging environment

More information

Result Update 06 November 2017

Result Update 06 November 2017 INDIA BUY Result Update 06 vember 2017 Financials Wheels set rolling We retain Buy on (SUF) with SOTP based TP at Rs2,030. Q2 18 results beat our estimates on all fronts higher than expected earnings;

More information

CMP* (Rs) 336 Upside/ (Downside) (%) 21 Bloomberg Ticker. MOIL IN Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133

CMP* (Rs) 336 Upside/ (Downside) (%) 21 Bloomberg Ticker. MOIL IN Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133 4QFY17 Result Update June 06, 2017 Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133 Mixed Quarterly Performance; Volume to Remain Strong has reported a mixed performance in 4QFY17. Its blended

More information

Ambuja Cements NEUTRAL. Performance Highlights CMP. `155 Target Price - 1QCY2011 Result Update Cement. Investment Period - Key financials (Standalone)

Ambuja Cements NEUTRAL. Performance Highlights CMP. `155 Target Price - 1QCY2011 Result Update Cement. Investment Period - Key financials (Standalone) 1QCY2011 Result Update Cement April 29, 2011 Ambuja Cements Performance Highlights Y/E Dec. (` cr) 1QCY2011 4QCY2010 % chg qoq 1QCY2010 % chg yoy Net sales 2,207 1,788 23.4 1,990 10.9 Operating profit

More information

EBITDA 2,503 2,904 (13.8) 2,722 (8.0) EBITDA

EBITDA 2,503 2,904 (13.8) 2,722 (8.0) EBITDA 1QFY19 Result Update The Ramco Cements 3 August 218 Reuters: TRCE.BO; Bloomberg: TRCL IN Challenging Business Environment Aptly Handled The Ramco Cements (TRCL) reported a stable operating performance

More information

HOLD. Margins to improve from Q2 AMBUJA CEMENTS. Target Price: Rs 232. Other highlights

HOLD. Margins to improve from Q2 AMBUJA CEMENTS. Target Price: Rs 232. Other highlights AMBUJA S 4 MAY 2017 Quarterly Update HOLD Target Price: Rs 232 Margins to improve from Q2 Q1CY17standalone EBITDA at Rs 4.0 bn was in line withconsensus estimate.volume was up 3% YoY to 6 mnt. Realization

More information

Institutional Equities

Institutional Equities 2QFY18 Result Update Institutional Equities KCP 5 December 2017 Reuters: KCP.BO; Bloomberg: KCPL IN Other Income Drives PAT; High International Coal Price Is Cause For Concern KCP reported a weak set of

More information

ACC NEUTRAL. Performance Highlights. CMP `1,261 Target Price - 4QCY2012 Result Update Cement. Quarterly results (Standalone) Investment Period -

ACC NEUTRAL. Performance Highlights. CMP `1,261 Target Price - 4QCY2012 Result Update Cement. Quarterly results (Standalone) Investment Period - 4QCY2012 Result Update Cement February 11, 2013 ACC Performance Highlights Quarterly results (Standalone) Y/E Dec. (` cr) 4QCY2012 3QCY2012 % chg qoq 4QCY2011 % chg yoy Net sales 3,099 2,445 26.8 2,503

More information

Ambuja Cements ACCUMULATE. Performance Highlights. CMP Target Price `207 `233. 3QCY2015 Result Update Cement. Quarterly results (Standalone)

Ambuja Cements ACCUMULATE. Performance Highlights. CMP Target Price `207 `233. 3QCY2015 Result Update Cement. Quarterly results (Standalone) Ambuja Cements Performance Highlights Quarterly results (Standalone) Y/E Dec. (` cr) 3QCY2015 2QCY2015 % chg qoq 3QCY2014 % chg yoy Net Sales 2,095 2,493 (16.0) 2,188 (4.2) EBIDTA 310 384 (19.2) 393 (21.2)

More information

Tata Steel NEUTRAL. Performance Highlights CMP. `226 Target Price - 2QFY2016 Result Update Steel. Investment Period - 3-year price chart

Tata Steel NEUTRAL. Performance Highlights CMP. `226 Target Price - 2QFY2016 Result Update Steel. Investment Period - 3-year price chart 2QFY2016 Result Update Steel November 6, 2015 Tata Steel Performance Highlights Standalone (` cr) 2QFY16 2QFY15 yoy % 1QFY16 qoq % Net revenue 9,531 10,785 (11.6) 9,094 4.8 EBITDA 1,862 3,094 (39.8) 1,689

More information

Ahluwalia Contracts (India)

Ahluwalia Contracts (India) May-14 Jul-14 Aug-14 Sep-14 Oct-14 Dec-14 Jan-15 Feb-15 Apr-15 May-15 India Research Infrastructure May 22, 215 QUARTERLY REVIEW Bloomberg: AHLU IN Reuters: AHLU.BO BUY Better performance ahead ACIL posted

More information

SpiceJet ACCUMULATE. Performance Highlights. 4QFY2010 Result Update I Aviation

SpiceJet ACCUMULATE. Performance Highlights. 4QFY2010 Result Update I Aviation 4QFY2010 Result Update I Aviation June 3, 2010 SpiceJet Performance Highlights For 4QFY2010, SpiceJet s Top-line grew 34.3% yoy but fell 12.8% qoq to Rs560cr, slightly lower than our estimate of Rs590cr.

More information

Suzlon Energy Ltd RESULT UPDATE 16th August, 2017

Suzlon Energy Ltd RESULT UPDATE 16th August, 2017 RESULT UPDATE 16 th August, 2017 Aug-16 Oct-16 Dec-16 Feb-17 Apr-17 Jun-17 Aug-17 Please vote for us in Asiamoney Brokers Poll 2017: https://www.euromoney.com/article/b13j49qfcr6j pp/asiamoney-brokers-poll-2017-vote-now

More information

CMP (Rs) 775 Upside/ (Downside) (%) (1.4) Market Cap. (Rs bn) 11.4 Free Float (%) 35.0 Shares O/S (mn) 14.7

CMP (Rs) 775 Upside/ (Downside) (%) (1.4) Market Cap. (Rs bn) 11.4 Free Float (%) 35.0 Shares O/S (mn) 14.7 2QFY18 Result Update November 23, 2017 Market Cap. (Rs bn) 11.4 Free Float (%) 35.0 Shares O/S (mn) 14.7 High Order Book Provides Revenue Visibility (PMPL) has delivered a healthy performance in 2QFY18.

More information

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance RAMCO S HOLD Target Price: Rs 503 Deleveraging story playing out Ramco Cements total debt reduced by a massive Rs 5 bn to Rs 22 bn in FY16. The company generated total EBITDA of Rs 11.5 bn in FY16 and

More information

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart. Ltd. Creating value through paper Limited (RPL) manufactures writing paper, printing paper and Kraft paper. The company's white writing and printing paper is used in making notebooks and writing material,

More information

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution 2QFY19 Result Update Power Mech Projects 21 November 218 Reuters: POMP.BO; Bloomberg: POWM IN Strong Order Book Drives Robust Execution Power Mech Projects (PMPL) posted 2QFY19 consolidated revenues of

More information

Institutional Equities

Institutional Equities 4QFY18 Result Update Institutional Equities Atul Auto 30 May 2018 Reuters: ATUL.BO; Bloomberg: ATUL IN Higher Expenses Mar Profitability Atul Auto s (AAL) 4QFY18 earnings missed our expectations on account

More information

Ramco Cement. Rating: Target price: EPS: Rating CMP. Target BUY. Rs.415. Rs. 360

Ramco Cement. Rating: Target price: EPS: Rating CMP. Target BUY. Rs.415. Rs. 360 : price: EPS: How does our one year outlook change? We maintain our positive stance on s (TRCL). The company is one of the largest cement producers in South and remains among the best plays on Southern

More information

Cummins India Ltd Bloomberg Code: KKC IN

Cummins India Ltd Bloomberg Code: KKC IN Company Update Margins Under Pressure; Domestic Recovery Underway Half-yearly revenue was flat; margins were under pressure: Cummins India revenue, EBITDA and PAT for H1FY17 reached to Rs.24,784mn, Rs.4,649mn

More information

Indian Oil Corporation

Indian Oil Corporation 3QFY18 Result Update Institutional Equities Indian Oil Corporation 1 February 2018 Reuters: IOC.BO; Bloomberg: IOCL IN Earnings Outperformance On Account Of Inventory Gains Indian Oil Corporation (IOCL)

More information

All the more bullish, TP upgraded

All the more bullish, TP upgraded Sterlite Tech India Equity Research Small & Mid Cap April 18, 2017 Company Update Emkay Your success is our success All the more bullish, TP upgraded CMP Target Price Rs150 Rs208 ( ) Rating Upside BUY

More information

Colgate-Palmolive (India)

Colgate-Palmolive (India) Result Update Colgate-Palmolive (India) 27 July 218 Reuters: COLG.BO; Bloomberg: CLGT IN Tough Times Continue Colgate-Palmolive (India) or CLGT reported a mixed earnings performance in. Volume and revenue

More information

Amber Enterprises India Ltd

Amber Enterprises India Ltd 3QFY2019 Result Update Consumer Durable February 16, 2019 Amber Enterprises India Ltd Performance Update (` cr) 3QFY19 3QFY18 % yoy 2QFY19 % qoq Revenue 388.8 338.4 14.9 226.3 71.8 EBITDA 22.1 24.1 (8.2)

More information

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance 2QFY19 Result Update Gillette India 13 February 2019 Reuters: GILE.NS; Bloomberg: GILL IN Marketing Investments Mask Improved Top-line Performance Gillette India s (GILL) 2QFY19 operating and net earnings

More information

Nestle India Ltd. RESULT UPDATE

Nestle India Ltd. RESULT UPDATE RESULT UPDATE 15th May 2017 May-16 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 India Equity Institutional Research II Result Update Q1CY17 II 15th May, 2017 CMP INR 6819 Target INR 7075 Potential Upside

More information

Jamna Auto Industries

Jamna Auto Industries 2QFY19 Result Update Institutional Equities Jamna Auto Industries Reuters: JMNA.NS; Bloomberg: JMNA IN Performance Below Expectations; Retain Buy Due To Strong Outlook Jamna Auto s 2QFY19 earnings were

More information

UltraTech Cement (ULTCEM)

UltraTech Cement (ULTCEM) April 20, 2009 Cement Company Update UltraTech Cement (ULTCEM) Current Price Rs 546 Potential upside 15.4% Target Price Rs 630 Time Frame 12-15 months Powered by savings Historically, UltraTech Cement

More information

Ultratech Cement. Source: Company Data; PL Research

Ultratech Cement. Source: Company Data; PL Research Higher realisations drove the show; Price led recovery still away April 25, 2018 Kamlesh Bagmar kamleshbagmar@plindia.com +91 22 66322237 Amit Khimesra amitkhimesra@plindia.com +91 22 66322244 Rating Accumulate

More information

Parag Milk Foods BUY. Performance Update CMP. `324 Target Price `410. 1QFY2019 Result Update Dairy Products. Investment Period 12 Months

Parag Milk Foods BUY. Performance Update CMP. `324 Target Price `410. 1QFY2019 Result Update Dairy Products. Investment Period 12 Months 1QFY2019 Result Update Dairy Products August 8, 2018 Parag Milk Foods Performance Update Y/E March (` cr) Q1FY19 Q1FY18 % yoy Q4FY18 % qoq Net sales 549 413 32.9 518 5.9 EBITDA 60 29 103% 55 8.4% EBITDA

More information

CMP* (Rs) 263 Upside/ (Downside) (%) 7.3. Market Cap. (Rs bn) 635 Free Float (%) 59 Shares O/S (mn) 2,417

CMP* (Rs) 263 Upside/ (Downside) (%) 7.3. Market Cap. (Rs bn) 635 Free Float (%) 59 Shares O/S (mn) 2,417 2QFY18 Result Update November 01, 2017 Market Cap. (Rs bn) 635 Free Float (%) 59 Shares O/S (mn) 2,417 In-line Performance; Margins to Remain Strong (JSTL) has delivered an in-line performance in 2QFY18

More information

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months 2QFY2019 Result Update Dairy Products November 6, 2018 Parag Milk Foods Performance Update Y/E March (` cr) Q2FY19 Q2FY18 % yoy Q1FY19 % qoq Net sales 573 505 13.7% 549 4.4% EBITDA 58 50 16.3% 60-2.7%

More information

Adani Ports & SEZ Rating: Target price: EPS:

Adani Ports & SEZ Rating: Target price: EPS: Adani Ports & SEZ : price: EPS: Volume traction continues in a seasonally good quarter; maintain Adani Ports & SEZ reported a good quarter with total operating revenues (standalone) of Rs. 8.02bn and PAT

More information

ITC Ltd. RESULT UPDATE 27th October, 2017

ITC Ltd. RESULT UPDATE 27th October, 2017 . RESULT UPDATE 27th October, 2017 Oct-14 Apr-15 Oct-15 Apr-16 Oct-16 Apr-17 Oct-17 India Equity Institutional Research II Result Update - II 27th October, 2017 CMP INR 269 Target INR 349 Potential Upside

More information

Fineotex Chemical Ltd

Fineotex Chemical Ltd Company Update Decent Performance under Macroeconomic Pressure; Business Traction to Continue: Fineotex Chemical recorded decent set of result as consolidated sales grew by 1.1% YoY (largely in line) to

More information

Emkay. Demand environment remain weak. Century Plyboards. Result highlights. Slowdown in plywood segment impacted revenue growth

Emkay. Demand environment remain weak. Century Plyboards. Result highlights. Slowdown in plywood segment impacted revenue growth Century Plyboards India Equity Research Others January 29, 2016 Result Update Emkay Your success is our success Demand environment remain weak CMP Rs150 Target Price Rs166 ( ) Rating Upside ACCUMULATE

More information

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart 4QFY216 Result Update Capital Goods May 11, 216 Inox Wind Performance Highlights Quarterly Data (Consolidated) ( ` cr) 4QFY16 4QFY15 % chg (yoy) 3QFY16 % chg (qoq) Total Income 1,829 93 96.6 941 94.2 EBITDA

More information

CMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630

CMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630 1QFY18 Result Update July 28,2017 CMP* (Rs) 208 Bloomberg Ticker CROMPTON IN Market Cap. (Rs bn) 130.6 Free Float (%) 65.6 Shares O/S (mn) 630 Channel De-stocking Impairs Top-line; Recovery Ahead Crompton

More information

Key estimate revision. Financial summary. Year FY16E 29, % 3,583 2, FY17E 26, % 3,478 2,

Key estimate revision. Financial summary. Year FY16E 29, % 3,583 2, FY17E 26, % 3,478 2, : price: EPS: How does our one year outlook change? We maintain our negative stance on SKF India due to the absence of significant growth momentum drivers over the medium term. While railways could be

More information

Ambuja Cements NEUTRAL. Performance Highlights CMP. `184 Target Price - 2QCY2012 Result Update Cement. Quarterly results (Standalone)

Ambuja Cements NEUTRAL. Performance Highlights CMP. `184 Target Price - 2QCY2012 Result Update Cement. Quarterly results (Standalone) 2QCY2012 Result Update Cement Ambuja Cements Performance Highlights Quarterly results (Standalone) Y/E Dec. (` cr) 2QCY2012 1QCY2012 % chg qoq 2QCY2011 % chg yoy Net Sales 2,566 2,633 (2.6) 2,173 18.1

More information

India Cements Rating: Target price:

India Cements Rating: Target price: : price: EPS: Another weak quarter; Maintain SELL ICEM reported weak 2QFY14 results, with a revenue de-growth of 3.3% y-o-y and EBITDA de-growth of 37.8% y-o-y. Volumes de-grew by 3% y-o-y to 4mt. Realisations

More information

Simplex Infrastructures

Simplex Infrastructures May-14 Jul-14 Aug-14 Sep-14 Nov-14 Dec-14 Jan-15 Mar-15 Apr-15 May-15 India Research Infrastructure May 27, 2015 QUARTERLY REVIEW Bloomberg: SINF IN Reuters: SINF.BO HOLD Working capital ease to improve

More information

CMP* (Rs) 242 Upside/ (Downside) (%) 2. Market Cap. (Rs bn) 157 Free Float (%) 65.6 Shares O/S (mn) 630

CMP* (Rs) 242 Upside/ (Downside) (%) 2. Market Cap. (Rs bn) 157 Free Float (%) 65.6 Shares O/S (mn) 630 4QFY17 Result Update June 02,2017 Market Cap. (Rs bn) 157 Free Float (%) 65.6 Shares O/S (mn) 630 Decent Performance to Continue; Maintain Crompton Greaves Consumer Electricals (CGCEL) has delivered a

More information

Tata Steel BUY. Performance Highlights. 3QFY2010 Result Update I Steel

Tata Steel BUY. Performance Highlights. 3QFY2010 Result Update I Steel 3QFY2010 Result Update I Steel January 29, 2010 Tata Steel Performance Highlights Tata Steel s standalone 3QFY2010 net revenue increased by 33.2% yoy and 12.0% qoq to Rs6,307.5cr, ahead of our estimates

More information

Nestlé India Outlook Hazy; Valuations Prohibitive

Nestlé India Outlook Hazy; Valuations Prohibitive Nestlé India Outlook Hazy; Valuations Prohibitive Nestlé India s net sales, EBITDA and net profit surged by 35% yoy, 67% yoy & 116% yoy to Rs23.5bn, Rs4.5bn & Rs2.7bn, respectively in 3QCY16. This growth

More information

Amara Raja Batteries BUY. Performance Highlights. CMP `1,010 Target Price `1,167. 2QFY2017 Result Update Auto Ancillary. 3-year price chart

Amara Raja Batteries BUY. Performance Highlights. CMP `1,010 Target Price `1,167. 2QFY2017 Result Update Auto Ancillary. 3-year price chart 2QFY217 Result Update Auto Ancillary November 8, 216 Amara Raja Batteries Performance Highlights BUY CMP `1,1 Target Price `1,167 Y/E March (` cr) 3QFY16 3QFY15 % chg (yoy) 2QFY16 % chg (qoq) Net Sales

More information

Mahindra & Mahindra Ltd.

Mahindra & Mahindra Ltd. Jan-16 Apr-16 Jul-16 Oct-16 Jan-17 Apr-17 Jul-17 Oct-17 Jan-18 Apr-18 Jul-18 Oct-18 Jan-19 3QFY2019 Result Update Automobile February 15, 2019 Mahindra & Mahindra Ltd. Performance Update Y/E March (` cr)

More information

Gillette India. Institutional Equities. 1QFY18 Result Update

Gillette India. Institutional Equities. 1QFY18 Result Update 1QFY18 Result Update Institutional Equities Gillette India 14 November 2017 Reuters: GILE.NS; Bloomberg: GILL IN Robust Growth In Operating Margin Gillette India s or GIL s overall top-line performance

More information

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months 2QFY217 Result Update Textile November 16, 216 Garware Wall Ropes Performance Highlights Quarterly Data (`cr) 2QFY17 2QFY16 % yoy 1QFY17 % qoq Revenue 232 214 8.5 225 3.3 EBITDA 4 26 5.9 31 29.4 Margin

More information

Indian Oil Corporation

Indian Oil Corporation 4QFY18 Result Update Institutional Equities Indian Oil Corporation 24 May 2018 Reuters: IOC.BO; Bloomberg: IOCL IN Subdued Earnings Because Of Lower GRM and Higher Expenses Indian Oil Corporation (IOCL)

More information

R-Power Suzlon. JSW Energy NHPC

R-Power Suzlon. JSW Energy NHPC R-Power Suzlon JSW Energy NHPC Sell: Reliance Power Buy: JSW Energy Rationale to Sell R-Power: R-Power is trading at a P/E of 17x while JSW Energy at current price is trading at a P/E of 9x. Despite having

More information

Robust results, TLT margins improved profitability.

Robust results, TLT margins improved profitability. Power Transmission Equipment Result Update Skipper Ltd BUY Robust results, TLT margins improved profitability. Institutional Research Nifty: 8,4; Sensex: 26,553 CMP (Rs) 153 Target (Rs) 17 Key Stock Data

More information

Coal India. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research Misses estimates; Higher costs dims hope for earnings recovery February 13, 2017 Kamlesh Bagmar kamleshbagmar@plindia.com +91 22 66322237 Rating Reduce Price Rs325 Target Price Rs320 Implied Upside 1.5%

More information

Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE

Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE 2QFY18 Result Update Institutional Equities Swaraj Engines 13 November 2017 Reuters: SWAR.BO; Bloomberg: SWE IN Strong Realisation Drives Earnings Growth Swaraj Engines (SEL) 2QFY18 earnings were 5% above

More information

Infibeam Incorporation Ltd.

Infibeam Incorporation Ltd. RESULT UPDATE 16 th August, 2017 Aug-16 Oct-16 Dec-16 Feb-17 Apr-17 Jun-17 Aug-17 Please vote for us in Asiamoney Brokers Poll 2017: https://www.euromoney.com/article/b13j49qfcr6j pp/asiamoney-brokers-poll-2017-vote-now

More information

Cement. Pet coke ban to dent margins in short-term. Sector Update. ICICI Securities Ltd Retail Equity Research. November 20, 2017

Cement. Pet coke ban to dent margins in short-term. Sector Update. ICICI Securities Ltd Retail Equity Research. November 20, 2017 Sector Update Sectoral View Cement Positive Rating matrix Companies Rating Target Price Old Revised Old Revised Shree Cement Hold Hold 19700 19000 JK Lakshmi Cement Buy Buy 495 470 Mangalam Cement Buy

More information

Mahindra & Mahindra Ltd.

Mahindra & Mahindra Ltd. Nov-15 Jan-16 Apr-16 Jul-16 Oct-16 Jan-17 Apr-17 Jul-17 Oct-17 Jan-18 Apr-18 Jul-18 Oct-18 2QFY2019 Result Update Automobile November 15, 2018 Mahindra & Mahindra Ltd. Performance Update Y/E March (` cr)

More information

Coal India ACCUMULATE. Performance Highlights CMP. `338 Target Price `380. Outlook and valuation. 2QFY2016 Result Update Mining

Coal India ACCUMULATE. Performance Highlights CMP. `338 Target Price `380. Outlook and valuation. 2QFY2016 Result Update Mining Coal India Performance Highlights (` cr) % yoy % qoq Net Sales 16,958 15,678 8.2 18,956 (1.5) EBITDA 3,8 2,556 17.7 4,944 (39.2) % margin 17.2 15.8 139bp 25.3 (813bp) Net Profit 2,519 2,188 15.2 3,787

More information

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS.

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS. Jan-14 Mar-14 Apr-14 May-14 Jul-14 Aug-14 Sep-14 Nov-14 Dec-14 Jan-15 India Research Infrastructure April 10, 2015 EVENT UPDATE Bloomberg: IN Reuters: HCNS.BO BUY QIP step in the right direction has successfully

More information

CCL Products BUY. Performance Update. CMP Target Price `278 `360. 3QFY2018 Result Update Coffee. Historical share price chart.

CCL Products BUY. Performance Update. CMP Target Price `278 `360. 3QFY2018 Result Update Coffee. Historical share price chart. Feb-15 May-15 Aug-15 Oct-15 Jan-16 Apr-16 Jul-16 Oct-16 Jan-17 Apr-17 Jul-17 Oct-17 Jan-18 3QFY2018 Result Update Coffee February 5, 2018 CCL Products Performance Update Y/E March (` cr) Q3FY18 Q3FY17

More information

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E.

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E. At inflection point Q2FY18 adjusted PAT grew 12% YoY at Rs 27 bn (vs. our estimate Rs 26 bn) in tandem with 17% YoY rise in regulated equity. Core RoE is still healthy at 20.2% though it contracted ~174

More information

FY17 FY18 FY19E FY20E

FY17 FY18 FY19E FY20E 3-Aug-15 3-Oct-15 3-Dec-15 3-Feb-16 3-Apr-16 3-Jun-16 3-Aug-16 3-Oct-16 3-Dec-16 3-Feb-17 3-Apr-17 3-Jun-17 3-Aug-17 3-Oct-17 3-Dec-17 3-Feb-18 3-Apr-18 3-Jun-18 Result Update STRONG BUY * August 6, 218

More information

Sanghvi Movers Ltd. Results above estimates. Figure 1: Actual Vs Religare Estimates. Financial highlights. Valuations and Recommendation

Sanghvi Movers Ltd. Results above estimates. Figure 1: Actual Vs Religare Estimates. Financial highlights. Valuations and Recommendation Institutional Equity Research Key data 3 June 28 Sector Capital Goods Market Cap Rs9bn/US$.2bn 52 Wk H/L (Rs) 337/15.5 BSE Avg. daily vol. (6m) 4,437 BSE Code 5373 NSE Code SANGHVIMOV Bloomberg SGM IN

More information

Key estimate revision. Financial summary. Year FY14 391,088 45,198 34, FY15E 354,262 35,426 23,

Key estimate revision. Financial summary. Year FY14 391,088 45,198 34, FY15E 354,262 35,426 23, : price: EPS: How does our one year outlook change? We retain our negative stance on the stock. We expect s revenue to de-grow by 9% y-o-y on the back of muted execution (client side and clearance delays)

More information

Karur Vysya Bank (KVB) KVB IN; KVB.BO

Karur Vysya Bank (KVB) KVB IN; KVB.BO Banking India (KVB) KVB IN; KVB.BO Institutional Equity Research May 2, 2015 result review HOLD Consolidating growth, high capital, elevated slippages Current price (30 Apr) Rs 482 Target price Rs 560

More information

Power Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy

Power Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy 2QFY18 Result Update Power Mech Projects 23 November 217 Reuters: POMP.BO; Bloomberg: POWM IN Strong Business Scalability Likely; Retain Buy Power Mech Projects (PMPL) posted 2QFY18 consolidated revenues

More information

Change EPS. (Rs) FY

Change EPS. (Rs) FY 17 AUG 217 / Quarterly Update BUY Target Price: Rs. 662 : Revenue up 21% Y-o-Y, strong growth in Non-GLE segment GMM Pfaudler Ltd(GMM) in 1QFY18posted revenues of Rs 69 Cr. (up 21% Y-o-Y, down 13% Q-o-Q)

More information

CMP* (Rs) 1,458 Upside/ (Downside) (%) 10 Bloomberg Ticker. ABB IN Market Cap. (Rs bn) 309 Free Float (%) 25 Shares O/S (mn) 212

CMP* (Rs) 1,458 Upside/ (Downside) (%) 10 Bloomberg Ticker. ABB IN Market Cap. (Rs bn) 309 Free Float (%) 25 Shares O/S (mn) 212 2QCY17 Result Update July 20, 2017 Market Cap. (Rs bn) 309 Free Float (%) 25 Shares O/S (mn) 212 Well-placed in Power T&D Hi-tech Space; Order Book Remains Robust India s revenue rose by 6.0% YoY to Rs23.3bn

More information

Colgate-Palmolive India Ltd.

Colgate-Palmolive India Ltd. RESULT UPDATE 5th February, 2018 Feb-15 Aug-15 Feb-16 Aug-16 Feb-17 Aug-17 Feb-18 India Equity Institutional Research II Result Update - Q3FY18 II 5th February, 2018 CMP INR 1,120 MARKET DATA Target INR

More information

Dalmia Bharat Enterprises

Dalmia Bharat Enterprises Result Update Institutional Equities Dalmia Bharat Enterprises Reuters: DALA.BO; Bloomberg: DBEL IN 14 August 218 Listless Performance, But Valuation Premium Continues Dalmia Bharat Enterprises (DBEL)

More information

TV Today Network BUY. Performance Update CMP. `323 Target Price `498. 3QFY2019 Result Update Media. Investment Period 12 Months

TV Today Network BUY. Performance Update CMP. `323 Target Price `498. 3QFY2019 Result Update Media. Investment Period 12 Months Jan-16 Apr-16 Jul-16 Oct-16 Jan-17 Apr-17 Jul-17 Oct-17 Jan-18 Apr-18 Jul-18 Oct-18 Jan-19 3QFY2019 Result Update Media February 14, 2019 TV Today Network Performance Update Y/E March (` cr) 3QFY19 3QFY18

More information

Sanofi India. Institutional Equities. 3QCY18 Result Update. Robust Performance BUY

Sanofi India. Institutional Equities. 3QCY18 Result Update. Robust Performance BUY 3QCY18 Result Update Institutional Equities Sanofi India Reuters: SANO.BO; Bloomberg: SANL IN Robust Performance Sanofi India s revenues in 3QCY18 stood at Rs7,438mn which were above our/consensus estimate

More information

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1% 4QFY18 Result Update Institutional Equities ITC 17 May 2018 Reuters: ITC.NS; Bloomberg: ITC IN Tracking Expectations ITC s growth in 4QFY18 was modest and in line with expectations. On the revenue side,

More information

CMP* (Rs) 166 Upside/ (Downside) (%) 28 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,361 Free Float (%) 37.7 Shares O/S (mn) 8,245

CMP* (Rs) 166 Upside/ (Downside) (%) 28 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,361 Free Float (%) 37.7 Shares O/S (mn) 8,245 3QFY18 Result Update February 05, 2018 CMP* (Rs) 166 Market Cap. (Rs bn) 1,361 Free Float (%) 37.7 Shares O/S (mn) 8,245 Wage Provisioning, Lower in Plant Availability Impede Earnings Growth has delivered

More information

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months 3QFY2017 Result Update FMCG January 30, 2017 ITC Performance Highlights Quarterly result (Standalone) (` cr) 3QFY17 3QFY16 % yoy 2QFY17 %qoq Revenue 9,248 8,867 4.3 9,661 (4.3) EBITDA 3,546 3,475 2.1 3,630

More information

Hindustan Media Ventures

Hindustan Media Ventures 2QFY216 Result Update Media October 27, 215 Hindustan Media Ventures Performance Highlights Quarterly Data (` cr) 2QFY16 2QFY15 % yoy 1QFY15 % qoq Revenue 227 2 13.7 224 1.4 EBITDA 52 39 33.1 55 (4.5)

More information